.png){kind=icon}
返回
Cutaneous leishmaniasis
.png){kind=icon}
PRE
AI
DOI：10.1016/S1473-3099(07)70209-8.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Cutaneous leishmaniasis is endemic in the tropics and neotropics. It is often referred to as a group of diseases because of the varied spectrum of clinical manifestations, which range from small cutaneous nodules to gross mucosal tissue destruction. Cutaneous leishmaniasis can be caused by several Leishmania spp and is transmitted to human beings and animals by sandflies. Despite its increasing worldwide incidence, but because it is rarely fatal, cutaneous leishmaniasis has become one of the so-called neglected diseases, with little interest by financial donors, public-health authorities, and professionals to implement activities to research, prevent, or control the disease. In endemic countries, diagnosis is often made clinically and, if possible, by microscopic examination of lesion biopsy smears to visually confirm leishmania parasites as the cause. The use of more sophisticated diagnostic techniques that allow for species identification is usually restricted to research or clinical settings in non-endemic countries. The mainstays of cutaneous leishmaniasis treatment are pentavalent antimonials, with new oral and topical treatment alternatives only becoming available within the past few years; a vaccine currently does not exist. Disease prevention and control are difficult because of the complexity of cutaneous leishmaniasis epizoology, and the few options available for effective vector control.
Keyword:
INTRALESIONAL MEGLUMINE ANTIMONIATE
CONTROLLED CLINICAL-TRIAL
SODIUM STIBOGLUCONATE PENTOSTAM
INSECTICIDE-TREATED BEDNETS
PLACEBO-CONTROLLED TRIAL
NATURAL-KILLER-CELLS
DOUBLE-BLIND TRIAL
MUCOCUTANEOUS LEISHMANIASIS
MUCOSAL LEISHMANIASIS
VIANNIA BRAZILIENSIS
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
31
论文数:
7.9K
被引数:
4.0W
机构
暂无机构信息
引用论文
.png){kind=icon}
分享收藏
查看更多内容